Sleep Number Under Investigation as Shares Plunge 22.45%
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 4 hours ago
0mins
Source: Globenewswire
- Earnings Miss: Sleep Number's Q1 2026 financial results, released on May 12, revealed an 18.9% year-over-year decline in earnings per share, significantly missing consensus estimates and undermining investor confidence.
- Guidance Suspension: The company also suspended its financial guidance, further exacerbating market uncertainty regarding its future performance, which could impact investor decision-making.
- Stock Price Plunge: Following the earnings report, Sleep Number's shares plummeted by 22.45% on the same day, reflecting serious concerns about the company's financial health among investors.
- Legal Investigation Initiated: The Schall Law Firm has launched an investigation into whether Sleep Number issued false or misleading statements, potentially exposing the company to legal liabilities under securities laws.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy SNBR?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on SNBR
Wall Street analysts forecast SNBR stock price to rise
2 Analyst Rating
0 Buy
2 Hold
0 Sell
Hold
Current: 1.800
Low
5.00
Averages
5.50
High
6.00
Current: 1.800
Low
5.00
Averages
5.50
High
6.00
About SNBR
Sleep Number Corporation is a wellness technology company. The Company is engaged in designing, manufacturing, marketing, and distribution of sleep solutions. Its wellness technology platform helps solve sleep problems, whether it’s providing individualized temperature control for each sleeper through its Climate360 smart bed or applying its 24 billion hours of longitudinal sleep data and expertise to research with global institutions. The Company’s smart beds provide unmatched features, benefits and comfort that can lead to improved sleep health and wellness for both sleepers. Its active temperature balancing technology supports the ideal climate for both sleepers and solves a prevalent sleep challenge. The Company’s smart bed ecosystem includes a full line of FlexFit smart adjustable bases that seamlessly integrate with Sleep Number smart beds for an individualized sleep experience that is proven to deliver more restful sleep per night.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Sleep Number Under Investigation as Shares Plunge 22.45%
- Earnings Miss: Sleep Number's Q1 2026 financial results, released on May 12, revealed an 18.9% year-over-year decline in earnings per share, significantly missing consensus estimates and undermining investor confidence.
- Guidance Suspension: The company also suspended its financial guidance, further exacerbating market uncertainty regarding its future performance, which could impact investor decision-making.
- Stock Price Plunge: Following the earnings report, Sleep Number's shares plummeted by 22.45% on the same day, reflecting serious concerns about the company's financial health among investors.
- Legal Investigation Initiated: The Schall Law Firm has launched an investigation into whether Sleep Number issued false or misleading statements, potentially exposing the company to legal liabilities under securities laws.
See More
Three Unprofitable Companies Face Challenges
- Asure Software Risk: Asure Software (ASUR) has a trailing 12-month GAAP operating margin of -2.7%, with a revenue increase of 12.3% over the past two years, but an estimated sales growth of only 10.4% for the next year may restrict its ability to invest or reward shareholders.
- Sleep Number Profitability Decline: Sleep Number (SNBR) shows a trailing 12-month GAAP operating margin of -6.4%, with lagging same-store sales leading to a 44% annual drop in earnings per share, indicating a need for pricing and marketing strategy adjustments to stimulate demand.
- Sunrun Cash Flow Concerns: Sunrun (RUN) has a trailing 12-month GAAP operating margin of -1.7%, and its suboptimal cost structure along with cash-burning tendencies raises doubts about its ability to sustainably generate shareholder value, currently trading at $14.48 per share with a P/E ratio of 23.7.
- Market Environment Changes: These companies face increasing challenges amid heightened competition and funding difficulties, which could jeopardize their survival in the market, prompting investors to carefully assess their future prospects.
See More
Sleep Number Under Investigation Amid Poor Q1 Results
- Declining Financial Performance: Sleep Number reported Q1 2026 results with a GAAP EPS of -$2.19, missing consensus estimates by $1.72, and revenue of $318.99 million, reflecting an 18.9% year-over-year decline, indicating severe profitability challenges for the company.
- Suspension of Financial Guidance: The company suspended its financial guidance, citing the engagement of Guggenheim Securities to evaluate strategic and financing options, which suggests a proactive approach to address its current financial difficulties.
- Significant Stock Price Drop: Following the earnings report, Sleep Number's stock price fell by $0.55, or 22.45%, closing at $1.90 per share, reflecting investor concerns regarding the company's future outlook and financial health.
- Legal Investigation Initiated: Pomerantz LLP is investigating whether Sleep Number and its executives engaged in securities fraud or other unlawful business practices, potentially leading to a class action lawsuit, which could further exacerbate market concerns about its governance structure.
See More
Sleep Number Q1 2026 Earnings Call Insights
- Liquidity Improvement: Sleep Number reached an agreement with existing lenders that adds $55 million in liquidity, including a new $25 million term loan, allowing time to focus on a long-term capital structure solution, thereby alleviating short-term financial pressures.
- Sales Performance Recovery: The company reported net sales of $319 million in Q1, which, while 19% lower year-over-year, aligns with analysts' expectations of $321 million, demonstrating resilience in the market recovery despite macroeconomic uncertainties.
- Product Line Success: The newly launched ComfortNext Lux mattress has become the top-selling product at approximately $4,000, and during the launch period, stores featuring the new lineup saw a 12% higher average revenue per unit (ARU) compared to previous products, indicating positive consumer reception.
- Effective Cost Control: Since the beginning of 2025, the company has identified over $235 million in annualized savings, with $200 million already executed, showcasing effective cost management that supports future profitability enhancements.
See More
Sleep Number Q1 Earnings Miss Expectations with Significant Losses
- Severe Earnings Loss: Sleep Number reported a Q1 GAAP EPS of -$2.19, missing expectations by $1.72, indicating significant challenges in profitability for the company.
- Revenue Decline: The company generated $318.99 million in revenue for Q1, an 18.9% year-over-year decrease, failing to meet expectations and reflecting pressures from weak market demand and declining sales.
- Adjusted EBITDA Drop: Adjusted EBITDA fell to $6 million, down 74%, primarily driven by a decline in net sales and associated loss of fixed cost leverage, although partially offset by lower operating expenses.
- Deteriorating Cash Flow: Year-to-date, net cash used in operating activities was $8 million, down $5 million from last year, with free cash flow showing a use of $13.2 million, highlighting difficulties in cash flow management.
See More
Sleep Number Secures $55M Liquidity Boost Amid Turnaround Efforts
- Liquidity Agreement: Sleep Number has reached an agreement with lenders to secure $55 million in liquidity, including a $25 million term loan, which provides essential funding to support its turnaround strategy and maintain competitiveness in the market.
- Covenant Relief: The agreement also eases certain financial and liquidity covenants, allowing the company greater flexibility to execute its product and marketing plans, particularly as it approaches the Memorial Day selling season, which is expected to drive sales growth.
- Stock Surge: Sleep Number's shares soared over 34% in premarket trading to $2.97; however, the stock remains more than 75% below its 52-week high, indicating market caution regarding its long-term recovery potential.
- Strategic Restructuring: The CFO highlighted that Sleep Number will continue to prioritize resetting its capital structure while planning to roll out a new product portfolio and marketing campaign to maximize value and attract more consumers.
See More
Sleep Number Under Investigation as Shares Plunge 22.45%
- Earnings Miss: Sleep Number's Q1 2026 financial results, released on May 12, revealed an 18.9% year-over-year decline in earnings per share, significantly missing consensus estimates and undermining investor confidence.
- Guidance Suspension: The company also suspended its financial guidance, further exacerbating market uncertainty regarding its future performance, which could impact investor decision-making.
- Stock Price Plunge: Following the earnings report, Sleep Number's shares plummeted by 22.45% on the same day, reflecting serious concerns about the company's financial health among investors.
- Legal Investigation Initiated: The Schall Law Firm has launched an investigation into whether Sleep Number issued false or misleading statements, potentially exposing the company to legal liabilities under securities laws.
See More
Three Unprofitable Companies Face Challenges
- Asure Software Risk: Asure Software (ASUR) has a trailing 12-month GAAP operating margin of -2.7%, with a revenue increase of 12.3% over the past two years, but an estimated sales growth of only 10.4% for the next year may restrict its ability to invest or reward shareholders.
- Sleep Number Profitability Decline: Sleep Number (SNBR) shows a trailing 12-month GAAP operating margin of -6.4%, with lagging same-store sales leading to a 44% annual drop in earnings per share, indicating a need for pricing and marketing strategy adjustments to stimulate demand.
- Sunrun Cash Flow Concerns: Sunrun (RUN) has a trailing 12-month GAAP operating margin of -1.7%, and its suboptimal cost structure along with cash-burning tendencies raises doubts about its ability to sustainably generate shareholder value, currently trading at $14.48 per share with a P/E ratio of 23.7.
- Market Environment Changes: These companies face increasing challenges amid heightened competition and funding difficulties, which could jeopardize their survival in the market, prompting investors to carefully assess their future prospects.
See More
Sleep Number Under Investigation Amid Poor Q1 Results
- Declining Financial Performance: Sleep Number reported Q1 2026 results with a GAAP EPS of -$2.19, missing consensus estimates by $1.72, and revenue of $318.99 million, reflecting an 18.9% year-over-year decline, indicating severe profitability challenges for the company.
- Suspension of Financial Guidance: The company suspended its financial guidance, citing the engagement of Guggenheim Securities to evaluate strategic and financing options, which suggests a proactive approach to address its current financial difficulties.
- Significant Stock Price Drop: Following the earnings report, Sleep Number's stock price fell by $0.55, or 22.45%, closing at $1.90 per share, reflecting investor concerns regarding the company's future outlook and financial health.
- Legal Investigation Initiated: Pomerantz LLP is investigating whether Sleep Number and its executives engaged in securities fraud or other unlawful business practices, potentially leading to a class action lawsuit, which could further exacerbate market concerns about its governance structure.
See More
Sleep Number Q1 2026 Earnings Call Insights
- Liquidity Improvement: Sleep Number reached an agreement with existing lenders that adds $55 million in liquidity, including a new $25 million term loan, allowing time to focus on a long-term capital structure solution, thereby alleviating short-term financial pressures.
- Sales Performance Recovery: The company reported net sales of $319 million in Q1, which, while 19% lower year-over-year, aligns with analysts' expectations of $321 million, demonstrating resilience in the market recovery despite macroeconomic uncertainties.
- Product Line Success: The newly launched ComfortNext Lux mattress has become the top-selling product at approximately $4,000, and during the launch period, stores featuring the new lineup saw a 12% higher average revenue per unit (ARU) compared to previous products, indicating positive consumer reception.
- Effective Cost Control: Since the beginning of 2025, the company has identified over $235 million in annualized savings, with $200 million already executed, showcasing effective cost management that supports future profitability enhancements.
See More
Sleep Number Q1 Earnings Miss Expectations with Significant Losses
- Severe Earnings Loss: Sleep Number reported a Q1 GAAP EPS of -$2.19, missing expectations by $1.72, indicating significant challenges in profitability for the company.
- Revenue Decline: The company generated $318.99 million in revenue for Q1, an 18.9% year-over-year decrease, failing to meet expectations and reflecting pressures from weak market demand and declining sales.
- Adjusted EBITDA Drop: Adjusted EBITDA fell to $6 million, down 74%, primarily driven by a decline in net sales and associated loss of fixed cost leverage, although partially offset by lower operating expenses.
- Deteriorating Cash Flow: Year-to-date, net cash used in operating activities was $8 million, down $5 million from last year, with free cash flow showing a use of $13.2 million, highlighting difficulties in cash flow management.
See More
Sleep Number Secures $55M Liquidity Boost Amid Turnaround Efforts
- Liquidity Agreement: Sleep Number has reached an agreement with lenders to secure $55 million in liquidity, including a $25 million term loan, which provides essential funding to support its turnaround strategy and maintain competitiveness in the market.
- Covenant Relief: The agreement also eases certain financial and liquidity covenants, allowing the company greater flexibility to execute its product and marketing plans, particularly as it approaches the Memorial Day selling season, which is expected to drive sales growth.
- Stock Surge: Sleep Number's shares soared over 34% in premarket trading to $2.97; however, the stock remains more than 75% below its 52-week high, indicating market caution regarding its long-term recovery potential.
- Strategic Restructuring: The CFO highlighted that Sleep Number will continue to prioritize resetting its capital structure while planning to roll out a new product portfolio and marketing campaign to maximize value and attract more consumers.
See More
